Taiwan FDA registration 61f897a84d594013bf52b240c42c2085
Icitabrazin 2 calibration antibody (unsterilized)
TW: 宜立亞鈣衛蛋白2標定抗體(未滅菌)
Taiwan·Risk Class 1·PHADIA AB;; PHADIA GMBH·Registered Dec 13, 2017 – Dec 13, 2027ActiveRegistration details
- Analysis ID
- 61f897a84d594013bf52b240c42c2085
- Customs Code
- DHA09401860208
Company information
- Manufacturer
- PHADIA AB;; PHADIA GMBH
- Manufacturer Country
- Sweden;;Germany
- Authorized Representative
- PHADIA TAIWAN INC.
Product details
- Intended Use
- Limited to the first level identification range of the Measures for the Classification and Grading of Medical Devices "Analysis of Specific Reagents (B.4020)".
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Dec 13, 2017
- Expiry Date
- Dec 13, 2027
About this record
Access comprehensive regulatory information for Icitabrazin 2 calibration antibody (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 61f897a84d594013bf52b240c42c2085 and manufactured by PHADIA AB;; PHADIA GMBH. The authorized representative in Taiwan is PHADIA TAIWAN INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices